High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic Neuritis
Roy W. Beck(Charlottesville Medical Research), Michael Wall(Dudley Group NHS Foundation Trust), M. Tariq Bhatti, Jonathan D. Trobe(University of Toronto), William T. Shults(Unknown), Sarkis M. Nazarian, Georgia Antonakou Chrousos, Eric Eggenberger(Michigan State University), Mark J. Kupersmith(New York Eye and Ear Infirmary), Robin L. Gal(W.K. Kellogg Foundation), Pamela S. Moke, Silvia Orengo-Nania, James J. Corbett(Wellington Hospital), David I. Kaufman(Michigan State University), Craig H. Smith, Michael C. Brodsky, Peter J. Savino(Smith-Kettlewell Eye Research Institute), Neil R. Miller(Johns Hopkins University), Dongyuan Xing, John L. Keltner(Washington University in St. Louis), James Goodwin(University of Illinois Chicago), Barrett Katz, Edward G. Buckley(Duke University)
Cited by 400
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k
A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis
|New England Journal of Medicine|1992|1.3k
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
|New England Journal of Medicine|2019|960
Approaching Health Disparities From a Population Perspective: The National Institutes of Health Centers for Population Health and Health Disparities
|American Journal of Public Health|2008|565